Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
NCT ID: NCT05795894
Last Updated: 2024-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10 participants
OBSERVATIONAL
2022-07-12
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypotheses to explain the increase in the rate of suicidal crisis will be addressed through semi-structured interviews proposed to the participants of the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period
NCT07302295
Discordance in the Evaluation of Suicidal Intent Between Parents and Adolescents in Adolescence and Evolution of the Suicidal Crisis : a Mixed Study
NCT06036290
Qualitative Assessment of the Brief Contact Intervention "Stay in Contact" in Suicide Prevention
NCT03325478
Understanding and Acting to Regulate Suicidal Behavior
NCT06689657
Contribution of Psychological Autopsy to the Understanding of Suicidal Behaviors in French Overseas Territories
NCT05773898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These interviews will be based on a questionnaire established beforehand evoking the history of mental disorders and the experience of the participant in the study and his entourage of the Covid-19 health crisis.
All information exchanged during these interviews will be made anonymous (data collected and processed as well as the results presented). They will be used exclusively in the context of the study and not communicated to the medical team involved in the patient's care.
The proposed interviews will be carried out separately with:
* The patient who consulted the emergency room during the month of November 2021
* The parent(s) of the study participant
* One or more health professionals taking care of the patient
* The school attended by the patient who will be questioned about the suicidal problem and Covid-19 in general or not about the patient in particular.
* Child welfare professionals (ASE) potentially involved in the care of the study participant.
Questionnaires will also be carried out with patients in order to complete the assessment of their clinical condition at a distance from the psychological crisis:
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patents
Questionnaires
STAI-Y
Situational Anxiety and Trait Anxiety Inventory
BDI scale
• Beck Depression Inventory scale
M.I.N.I.Kid
Suicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent version
PCL-5
Post-traumatic Check List Scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
STAI-Y
Situational Anxiety and Trait Anxiety Inventory
BDI scale
• Beck Depression Inventory scale
M.I.N.I.Kid
Suicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent version
PCL-5
Post-traumatic Check List Scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 13 years and 17 years and 11 months
* Good understanding of written and oral French
* Collection of the informed consent of the patient and of one of the two parents or holder of parental authority
Exclusion Criteria
* Refusal of participation by the patient or one of the legal guardians
13 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Lenval
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louise-Emilie DUMAS, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation Lenval
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
hôpital Lenval
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-HPNCL-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.